isoniazid has been researched along with paclitaxel in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 17 (85.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Joshi, SP; Kulkarni, RR; Puranik, VG; Sarkar, D; Shurpali, K | 1 |
Charolkar, CR; Divse, JM; Khedkar, VM; Nawale, LU; Pore, VS; Sarkar, D | 1 |
He, WJ; Liu, YH; Wang, JF; Zhang, XX; Zhao, BQ; Zhou, XJ | 1 |
Arkile, M; Jadhav, N; Khedkar, VM; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD | 1 |
Chen, B; Li, K; Liao, L; Liu, Y; Qin, X; Tian, X; Tu, Z; Wang, F; Wang, J; Wei, X; Yang, X; Zhang, T; Zhou, X | 1 |
Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A | 1 |
Arkile, MA; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gill, CH; Khedkar, VM; Mahajan, PS; Nawale, LU; Nikam, MD; Sarkar, D | 1 |
He, WJ; Liu, YH; Peng, S; Wang, JF; Zhao, BQ; Zhou, XJ | 1 |
Javid, B; Kong, C; Liu, C; Qian, F; Wu, G; Zhu, J | 1 |
1 review(s) available for isoniazid and paclitaxel
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for isoniazid and paclitaxel
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antimycobacterial labdane diterpenes from Leucas stelligera.
Topics: Antitubercular Agents; Crystallography, X-Ray; Diterpenes; Drug Screening Assays, Antitumor; Flavones; Hep G2 Cells; Humans; India; Inhibitory Concentration 50; Lamiaceae; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular | 2013 |
Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
Topics: Antitubercular Agents; Bile Acids and Salts; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2015 |
Dicarabrol, a new dimeric sesquiterpene from Carpesium abrotanoides L.
Topics: Antineoplastic Agents, Phytogenic; Asteraceae; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Conformation; Sesquiterpenes; Structure-Activity Relationship | 2015 |
Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
Topics: Alcohol Oxidoreductases; Antineoplastic Agents; Antitubercular Agents; Bacterial Proteins; Cell Line, Tumor; Click Chemistry; Free Radical Scavengers; Humans; Hydrogen Bonding; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Thiazines; Triazoles | 2016 |
Antiviral Merosesquiterpenoids Produced by the Antarctic Fungus Aspergillus ochraceopetaliformis SCSIO 05702.
Topics: Antarctic Regions; Anti-Bacterial Agents; Antiviral Agents; Crystallography, X-Ray; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Inhibitory Concentration 50; Marine Biology; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pyrones; Sesquiterpenes; Soil Microbiology | 2016 |
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis | 2016 |
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Combinatorial Chemistry Techniques; Green Chemistry Technology; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidines; Tuberculosis | 2016 |
Synthesis and Antitubercular Activity of New Benzo[b]thiophenes.
Topics: | 2016 |
Antitubercular and cytotoxic tigliane-type diterpenoids from Croton tiglium.
Topics: Antineoplastic Agents, Phytogenic; Antitubercular Agents; Croton; Diterpenes; Drug Screening Assays, Antitumor; Humans; K562 Cells; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Spectrometry, Mass, Electrospray Ionization | 2016 |
Uniform and amorphous rifampicin microspheres obtained by freezing induced LLPS during lyophilization.
Topics: Administration, Inhalation; Cell Line; Chemistry, Pharmaceutical; Drug Carriers; Dynamic Light Scattering; Freeze Drying; Humans; Isoniazid; Macrophages; Microscopy, Electron, Scanning; Microspheres; Paclitaxel; Particle Size; Phagocytosis; Rifampin; Solubility; tert-Butyl Alcohol; Water; X-Ray Diffraction | 2015 |